Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_assertion type Assertion NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_head.
- NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_assertion description "[GCA patients in stage III and IV, with positive UGIC family history, and hypermethylation and down-expression of RKIP were most likely to develop metastatic disease and also showed the worse survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_provenance.
- NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_assertion evidence source_evidence_literature NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_provenance.
- NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_assertion SIO_000772 22983529 NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_provenance.
- NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_assertion wasDerivedFrom befree-20150227 NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_provenance.
- NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_assertion wasGeneratedBy ECO_0000203 NP605291.RAsV29Wmpy4PU5j0HqdpDFeV_2z28OG22ioXWJ0yFYRJY130_provenance.